top of page
Molecules

OPEN CALL
Are you a researcher developing a new vaccine and need support?

Apply now >>

TRANSVAC2 is now offering FREE services as part of ISIDORe!

isidore-logo_design_ISIDORe Logo .png

OPEN CALL for Applications

TRANSVAC2, renowned for high-quality vaccine development support, is thrilled to offer FREE services through the ISIDORe network. These are the focus areas for this call:​​

Adjuvant and Formulation Expertise (VFI) >>

Vaccine technologies, process development & production (iBet) >>

​

 

Eligible projects must target pathogens listed in the ISIDORe Open Calls.

Deadline: July 29th. 

Apply now>>

isidore-logo_design_ISIDORe Logo with tagline.png

The ISIDORe project assembles the largest and most diverse research and service-providing instrument to study infectious diseases in Europe, with expertise from structural biology to clinical trials.

ISIDORe brings together under the same umbrella 17 major European life sciences research infrastructures and infectious diseases networks, including to accelerate the generation of new knowledge and intervention tools to enhance Europe’s capacity for controlling (re)emerging and epidemic infectious diseases, starting with the COVID-19 pandemic.

TRANSVAC: New Vaccines Faster

TRANSVAC is a collaborative infrastructure project funded by the European Commission (EC), initially under the 7th Framework Programme (FP7) and currently under Horizon 2020.  The project is a joint effort of leading European groups working in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC is designed to accelerate vaccine development by enhancing European vaccine research and training, and increase sustainability of EC vaccine projects by implementing a permanent research infrastructure for early vaccine development.

bottom of page